LAG-3 is expressed on activated tumor-infiltrating lymphocytes (TILs) (for example CD4 and CD8 positive T-cells [19], T-regs [20,21] and B-lymphocytes), and it regulates T-cell function as an inhibitory ICP. This evidence concerns the gene LAG3 and neoplasm.